Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of vitamin D receptor signaling pathway activity. [GOC:BHF, GOC:mah]
The vitamin D receptor (VDR) signaling pathway is a complex and tightly regulated process that plays a crucial role in maintaining calcium homeostasis, bone health, immune function, and overall cellular function. The pathway is initiated by the binding of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active form of vitamin D, to the VDR. This binding event triggers a cascade of events that ultimately leads to the regulation of gene expression. Here is a detailed description of the biological process of regulation of the VDR signaling pathway:
1. **Vitamin D Metabolism and Activation:** The process begins with the conversion of 7-dehydrocholesterol (provitamin D3) to vitamin D3 (cholecalciferol) in the skin upon exposure to UVB radiation. Vitamin D3 is then transported to the liver where it undergoes hydroxylation to form 25-hydroxyvitamin D3 (25(OH)D3), the major circulating form of vitamin D. 25(OH)D3 is further hydroxylated in the kidneys to produce 1,25(OH)2D3, the active form of vitamin D, under the control of the enzyme 1α-hydroxylase. This final step is regulated by a complex feedback loop involving calcium levels, parathyroid hormone (PTH), and other factors.
2. **VDR Binding and Nuclear Translocation:** 1,25(OH)2D3 diffuses into target cells and binds to the VDR, a nuclear receptor protein. The binding of 1,25(OH)2D3 to VDR induces a conformational change in the receptor, allowing it to interact with the retinoid X receptor (RXR). The VDR-RXR heterodimer then binds to specific DNA sequences called vitamin D response elements (VDREs) located in the promoter regions of target genes.
3. **Gene Transcription and Regulation:** The binding of the VDR-RXR complex to VDREs initiates the recruitment of coactivator proteins and the formation of a transcription complex. This complex facilitates the recruitment of RNA polymerase II and the subsequent transcription of target genes.
4. **Regulation of Gene Expression:** The VDR signaling pathway regulates the expression of a wide range of genes involved in calcium homeostasis, bone metabolism, cell growth and differentiation, immune function, and other processes. Some key target genes include:
* **Calbindin D9k (Calbindin D28K):** This protein plays a critical role in calcium absorption in the intestines.
* **Calcitriol 24-hydroxylase (CYP24A1):** This enzyme degrades 1,25(OH)2D3, thus regulating the activity of the VDR pathway.
* **Osteocalcin:** A bone-specific protein involved in bone mineralization.
* **Parathyroid hormone (PTH):** This hormone regulates calcium levels in the blood.
* **Antimicrobial peptides:** These peptides play a role in immune defense.
5. **Regulation of VDR Signaling Pathway:** The VDR signaling pathway is tightly regulated at multiple levels to ensure appropriate responses to vitamin D levels. These regulatory mechanisms include:
* **Feedback Regulation:** The active form of vitamin D, 1,25(OH)2D3, itself downregulates its own synthesis by inhibiting the activity of 1α-hydroxylase in the kidneys.
* **Hormonal Regulation:** PTH, the main regulator of calcium homeostasis, can stimulate the synthesis of 1,25(OH)2D3.
* **Phosphorylation and Ubiquitination:** Post-translational modifications like phosphorylation and ubiquitination can alter the activity and stability of the VDR protein.
* **MicroRNA Regulation:** MicroRNAs can bind to VDR mRNA and inhibit its translation, thereby influencing VDR expression.
**Conclusion:** The VDR signaling pathway is a highly intricate and multifaceted process that plays a critical role in maintaining human health. Its regulation is essential for appropriate responses to vitamin D levels and for the maintenance of calcium homeostasis, bone health, immune function, and other vital processes. Understanding the intricacies of this pathway is crucial for the development of effective therapeutic strategies for vitamin D deficiency, osteoporosis, and other related diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Transcription intermediary factor 1-alpha | A transcription intermediary factor 1-alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15164] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
vanillin | Vanilla: A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS). | benzaldehydes; monomethoxybenzene; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite |
salicylaldehyde | o-hydroxybenzaldehyde: structure in first source | hydroxybenzaldehyde | nematicide; plant metabolite |
cyclopentanone | cyclopentanones | Maillard reaction product | |
cyclooctanone | |||
2-hydroxy-4-methoxybenzaldehyde | 2-hydroxy-4-methoxybenzaldehyde: from African medicinal plants: Mondia whitei (Apocynaceae), Rhus vulagaris (Anacardiaceae), Sclerocarya caffra (Anacardiaceae) | methoxybenzenes; phenols | |
i-bet726 | |||
dBET6 | organic molecular entity |